Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1575 of 3284 entries
View as:

Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

Phase: N/A Priority: Normal
NCT ID: NCT00608712 Org: User:
Start: 11/30/05 End: 08/31/06 Due: 08/31/07

Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability

Phase: N/A Priority: Normal
NCT ID: NCT01928381 Org: User:
Start: 11/30/13 End: 05/31/15 Due: 05/31/16

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)

Phase: N/A Priority: Normal
NCT ID: NCT00313209 Org: User:
Start: 04/30/06 End: 02/29/08 Due: 02/28/09

A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®

Phase: N/A Priority: Normal
NCT ID: NCT00244608 Org: User:
Start: 05/31/05 End: 03/31/07 Due: 03/31/08

Brilinta Taiwan Post Approval Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT02406248 Org: User:
Start: 04/23/15 End: 02/09/17 Due: 02/09/18

Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]

Phase: N/A Priority: Normal
NCT ID: NCT00094328 Org: User:
Start: 11/22/04 End: 12/06/17 Due: 12/06/18

Savolitinib vs. Sunitinib in MET-driven PRCC.

Phase: N/A Priority: Normal
NCT ID: NCT03091192 Org: User:
Start: 07/25/17 End: 12/31/25 Due: 12/31/26

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00252863 Org: User:
Start: 12/31/04 End: 05/31/06 Due: 05/31/07

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02976831 Org: User:
Start: 12/09/16 End: 05/30/17 Due: 05/30/18

ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00247481 Org: User:
Start: 09/30/02 End: 06/30/05 Due: 06/30/06

A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

Phase: N/A Priority: Normal
NCT ID: NCT01106781 Org: User:
Start: 08/31/10 End: 01/31/14 Due: 01/31/15

Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN

Phase: N/A Priority: Normal
NCT ID: NCT05309668 Org: User:
Start: 01/21/22 End: 04/28/28 Due: 04/28/29

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00085969 Org: User:
Start: 09/30/03 End: 01/31/04 Due: 01/31/05

Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00502060 Org: User:
Start: 08/31/04 End: 06/30/06 Due: 06/30/07

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00467649 Org: User:
Start: 05/31/07 End: 04/30/08 Due: 04/30/09

Arthralgia During Anastrozole Therapy for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00323479 Org: User:
Start: 06/30/06 End: 01/31/09 Due: 01/31/10

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02551874 Org: User:
Start: 10/20/15 End: 11/10/17 Due: 11/10/18

Korean Post-marketing Surveillance for Kombiglyze XR®

Phase: N/A Priority: Normal
NCT ID: NCT01754142 Org: User:
Start: 11/24/12 End: 09/01/16 Due: 09/01/17

A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05768360 Org: User:
Start: 04/25/23 End: 06/24/23 Due: 06/24/24

Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)

Phase: N/A Priority: Normal
NCT ID: NCT00880711 Org: User:
Start: 04/30/09 End: 12/31/10 Due: 12/31/11

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

Phase: N/A Priority: Normal
NCT ID: NCT00658918 Org: User:
Start: 09/30/04 End: 11/30/05 Due: 11/30/06

Evaluation of Atacand® (Candesartan) in Daily Medical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00837720 Org: User:
Start: 03/31/06 End: 06/30/07 Due: 06/30/08

Quality Project to Evaluate and Validate the FAST-O Rating Scale

Phase: N/A Priority: Normal
NCT ID: NCT00913731 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Acid-suppressing Drugs Pregnancy Asthma Offspring Study

Phase: N/A Priority: Normal
NCT ID: NCT01787435 Org: User:
Start: 06/30/12 End: 12/31/14 Due: 12/31/15

Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

Phase: N/A Priority: Normal
NCT ID: NCT04126499 Org: User:
Start: 01/13/20 End: 05/08/20 Due: 05/08/21